Simultaneous Coexistence of Thyrotropin-Prolactin-Secreting Adenoma and Papillary Thyroid Carcinoma

Table 1

Pertinent laboratory findings.

Investigations	Before admission	At admission	After surgery	After lanreotide	After cabergoline	Reference range
TSH (μIU/mL)	4.5–50	35	20	6	0.5	0.35–4.95
FT4 (pmol/L)	—	23	24	22	19	12–22
FT3 (pmol/L)	—	5.3	6.7	6.6	5.9	2.8–7.1
Thyroglobulin (ng/mL)	—	6.8	22.7	8	0.4	<1
α subunit (ng/mL)	—	4.9	—	—	—	0.6–1.5
α-GSU/TSH molar ratio	—	1.4	—	—	—	<1
LH (IU/L)	—	36.8	—	—	—	2.4–12.6
FSH (IU/L)	—	84.1	—	—	—	3.5–12.5
Estradiol (pmol/L)	—	51	—	—	—	46–607
Prolactin (mIU/L)	—	250	230	—	90	72–511
Cortisol (nmol/L)	—	525	—	—	—	171–536
ACTH (pg/mL)	—	40	—	—	—	7–63
IGF1 (μg/L)	—	102	—	—	—	93–245